Form 4 for BVS Bioventus Inc.
Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-16 · accession 0001578563-24-000303 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-18 | 2024-06-16 | BVS | Beyer Pat | Dir | M - OptEx | $0.00 | +965 | 49.9K | +2% | $0 |
| D | 2024-06-18 | 2024-06-16 | BVS | Beyer Pat | Dir | M - OptEx | $0.00 | -965 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-16 | M | A | 965 | $0.00 | 49,943 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2024-06-16 | M | D | 965 | $0.00 | 0 | D | — · — to — | 965 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The 965 RSUs vested on June 16, 2024. |